These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10698042)

  • 1. Decreased expression of mac25 mRNA in uterine leiomyomata compared with adjacent myometrium.
    Kim JG; Kim MH; Kim IS; Moon SY; Kang SB; Lee HP; Lee JY
    Am J Reprod Immunol; 2000 Jan; 43(1):53-7. PubMed ID: 10698042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
    Vollenhoven BJ; Pearce P; Herington AC; Healy DL
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression.
    Dou Q; Tarnuzzer RW; Williams RS; Schultz GS; Chegini N
    Mol Hum Reprod; 1997 Nov; 3(11):1005-14. PubMed ID: 9433928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
    Levens E; Luo X; Ding L; Williams RS; Chegini N
    Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
    Wang H; Wu X; Englund K; Masironi B; Eriksson H; Sahlin L
    Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
    Chegini N; Verala J; Luo X; Xu J; Williams RS
    J Soc Gynecol Investig; 2003 Apr; 10(3):161-71. PubMed ID: 12699880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
    Luo X; Ding L; Chegini N
    Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
    Luo X; Levens E; Williams RS; Chegini N
    Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas.
    Sourla A; Polychronakos C; Zeng WR; Nepveu A; Kukuvitis A; Naud F; Koutsilieris M
    Cancer Res; 1996 Jul; 56(13):3123-8. PubMed ID: 8674071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA-expression of often used house-keeping genes and the relation between RNA and DNA are sex steroid-dependent parameters in human myometrium and fibroids.
    Wu X; Englund K; Lindblom B; Blanck A
    Gynecol Obstet Invest; 2003; 55(4):225-30. PubMed ID: 12904697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy.
    Luo X; Ding L; Xu J; Williams RS; Chegini N
    Endocrinology; 2005 Mar; 146(3):1074-96. PubMed ID: 15604208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone receptor messenger ribonucleic acid expression in leiomyoma and surrounding myometrium.
    Sharara FI; Nieman LK
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):814-9. PubMed ID: 7573249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata.
    Giudice LC; Irwin JC; Dsupin BA; Pannier EM; Jin IH; Vu TH; Hoffman AR
    Hum Reprod; 1993 Nov; 8(11):1796-806. PubMed ID: 7507128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
    Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin receptor and its messenger ribonucleic acid in human leiomyoma and myometrium.
    Lee KH; Khan-Dawood FS; Dawood MY
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):620-7. PubMed ID: 9757961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium.
    Vollenhoven BJ; Herington AC; Healy DL
    J Clin Endocrinol Metab; 1993 May; 76(5):1106-10. PubMed ID: 7684390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy.
    Dou Q; Zhao Y; Tarnuzzer RW; Rong H; Williams RS; Schultz GS; Chegini N
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3222-30. PubMed ID: 8784073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of latent TGF-beta binding protein-1 and fibrillin-1 in human uterine leiomyomata.
    Zhao Y; Wen Y; Polan ML; Qiao J; Chen BH
    Mol Hum Reprod; 2007 May; 13(5):343-9. PubMed ID: 17360930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of sex hormone-binding globulin mRNA in uterine leiomyoma, myometrium and endometrium of human subjects.
    Misao R; Nakanishi Y; Fujimoto J; Tamaya T
    Gynecol Endocrinol; 1995 Dec; 9(4):317-23. PubMed ID: 8629461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of exon 5 deleted estrogen receptor variant messenger RNA in human uterine myometrium and leiomyoma.
    Mito K; Tamura T; Hosokawa K; Kondo T; Yamamoto T; Honjo H
    J Steroid Biochem Mol Biol; 1998 Oct; 67(1):9-16. PubMed ID: 9780024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.